Ignite Creation Date:
2025-12-18 @ 9:46 AM
Ignite Modification Date:
2025-12-18 @ 9:46 AM
Study NCT ID:
NCT06113913
Status:
None
Last Update Posted:
2024-07-26 00:00:00
First Post:
2023-09-11 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Sponsor:
None
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-11 00:00:00
First Submit QC Date:
None
Study First Post Date:
2023-11-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-25 00:00:00
Last Update Post Date:
2024-07-26 00:00:00
Last Update Post Date Type:
ACTUAL